// App-Quantinova.ai

TCT-438 : Outcomes After Bailout Stenting with Absorb BVS or XIENCE: Meta-analysis of Randomized Trials

Researchers

Presenter

  • Stephen Ellis

Principal Investigators

  • Rony Lahoud

  • Xiaolu Su

  • Jennifer Jones

  • Robert McGreevy

  • Patrick Serruys

  • Gregg Stone

  • Dean Kereiakes

  • Run-Lin Gao

  • Takeshi Kimura

  • Yoshinobu Onuma

  • Wai-Fung Cheong

Medical Centers

  • Thoraxcenter, Erasmus Medical Center, Rotterdam, Rotterdam, Netherlands

  • Cardiovascular Research Foundation, Columbia University Medical Center/NewYork-Presbyterian Hospital, New York, New York, United States

  • Kyoto University, Kyoto, Japan

  • The Christ Hospital, Cincinnati, Ohio, United States

  • Fu Wai Hospital, Beijing, Beijing, China

  • Imperial College, London, United Kingdom

  • Cleveland Clinic Foundation, Cleveland, Ohio, United States

Locations

  • China

  • Japan

  • Netherlands

  • United Kingdom

  • United States

Companies

  • Abbott

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Myocardial infarction

  • Venous thrombosis

  • Coronary Artery Disease

Biomarkers

  • N/A

Drug/Treatment

  • Everolimus

  • ST-1

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim